Abstract:OBJECTIVE:To investigate the feasibility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in differentiating musculoskeletal tumors with different behaviours of pathological findings before therapy. METHODS:A total of 34 subjects of musculoskeletal tumors were involved in this retrospective analysis. DCE-MRI was performed using a fat-saturated 3D VIBE (volumetric interpolated breath-hold exam) imaging sequence with following parameters: FA, 10 degree; TR/TE, 5.6/2.4 ms; slice thickness, 4.0 mm with no intersection gap; field of view, 310 mm×213 mm; matrix, 256×178; voxel size, 1.2 mm×1.2 mm×4.0 mm; parallel imaging acceleration factor. The actuation time for the DCE-MRI sequence was 255 s with a temporal resolution of 5 s and 40 image volumes. Using pathological results as a gold standard, tumors were divided into benign, borderline and malignant tumors. Toft's model was used for calculation of K(trans) (volume transfer constant), Ve (extravascular extracellular space distribute volume per unit tissue volume) and Kep (microvascular permeability reflux constant). Those parameters were compared between the lesions and the control tissues using paired t tests. The one-way analysis of variance was used to assess the difference among benign, borderline and malignant tumors. P values <0.05 difference was statistically significant. RESULTS:Based on the WHO Classification of Tumours of Soft Tissue and Bone(2012) criteria, 34 patients were divided into three groups: 11 for benign tumors, 12 for borderline tumors, and 11 for malignancies. Compared with control tissues, K(trans) and Kep showed no difference, but Ve was increased in benign tumors, Kep showed no difference, but K(trans) and Ve were increased in borderline tumors,K(trans), Kep and Ve were increased in malignant tumors. K(trans) (P<0.001) and Kep (P<0.01) were significantly higher in malignant tumors than in benign and borderline tumors, but did not show any difference between benign tumors and borderline tumors. Ve was significantly higher in malignant tumors than in benign (P<0.05), but did not show any difference between malignant and borderline tumors, benign tumors and borderline tumors (P>0.05). CONCLUSION:DCE-MRI technique is useful to evaluate the pathological behaviour of musculoskeletal tumors. The quantitative analysis of DCE parameters in conjunction with conventional MR images can improve the accuracy of musculoskeletal tumor qualitative analysis.

Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.

Diagnostic Value of CT- and MRI-Based Texture Analysis and Imaging Findings for Grading Cartilaginous Tumors in Long Bones.

Study of DCE MRI and ~1H-MRS of giant cell tumor of bone

Imaging findings and differential diagnosis of cervical chordoma

A Computed Tomography Radiomics Nomogram in Differentiating Chordoma from Giant Cell Tumor in the Axial Skeleton

[Feasibility Study of Dynamic Contrast Enhanced Magnetic Resonance Imaging Qualitative Diagnosis of Musculoskeletal Tumors].

Evaluation of MRI and CT in diagnosing chordoma in the skull base

Imaging diagnosis and differential diagnosis of chordomas

The radiological findings of chordoid glioma: report of two cases, one case with MR spectroscopy

Differentiation of Primary Chordoma, Giant Cell Tumor and Schwannoma of the Sacrum by CT and MRI.

Triple-Phase Dynamic Mri: A New Clue to Predict Malignant Transformation of Giant Cell Tumor of Bone

A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.

CT and MR Imaging Diagnosis and Differential Diagnosis of Chordomas in the Skull Base

CT and MRI findings of the chordoma in the mobile spine

Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI

Evaluation of Quantitative Dynamic Contrast Enhanced MRI in Differential Diagnosis of Benign and Malignant Bone Tumors

Evaluation of the value of dynamic contrast-enhanced MRI for the diagnosis and follow-up of central cartilage tumors

Images of Giant Cell Tumor and Chondroblastoma Around the Knee: Retrospective Analysis of 99 Cases

Analysis for Imaging Characteristics of Chordoma

CT and MRI Features of Chondrosarcoma in the Mastoid Involving the Facial Nerve in Comparison to Facial Nerve Schwannoma

Analysis of MR Manifestation and Differential Diagnosis in Chordoma of the Skull Base